Imogam® – Human Rabies Vaccine
Imogam is an inactivated (killed) rabies virus vaccine produced from cell‑culture (usually Vero cells). It’s licensed for both post‑exposure prophylaxis (PEP)—the treatment you receive after a potential rabies exposure—and for pre‑exposure prophylaxis (PrEP)—vaccination before you might be exposed (e.g., for veterinarians, travelers to endemic areas, or laboratory workers).
---
1. How it’s used
| Indication | Typical dosing schedule (adult/child ≥ 12 kg) | Route |
|------------|----------------------------------------------|-------|
| Post‑exposure prophylaxis (PEP) | • Day 0 (the first day you’re seen) – 0.5 mL IM
• Day 3 – 0.5 mL IM
• Day 7 – 0.5 mL IM
• Day 14 – 0.5 mL IM (if using a 4‑dose schedule)
• Note: In many countries the 4‑dose schedule is used only for unvaccinated individuals who had a severe exposure (e.g., bite to the head/neck). For milder exposures, a 2‑dose schedule (days 0 & 3) may be sufficient. | Intramuscular (usually the thigh or deltoid) |
| Pre‑exposure prophylaxis (PrEP) | • Day 0 – 0.5 mL IM
• Day 7 – 0.5 mL IM
• Day 21 or 28 – 0.5 mL IM (the third dose can be given up to 28 days after the first) | Intramuscular |
- If you’re immunized (had the full PrEP series), you only need 2 IM doses (days 0 & 3) after an exposure.
- Immunoglobulin: For PEP, passive rabies immune globulin (RIG) should be given at the same time as the first vaccine dose, unless you’re already fully vaccinated. RIG supplies neutralizing antibodies immediately; the vaccine provides active immunity over weeks.
---
2. Contraindications & Precautions
| Category | Key Points |
|----------|------------|
| Contraindicated | • Severe allergy to any component of the vaccine (e.g., egg protein, gelatin).
• History of anaphylactic reaction to a rabies vaccine. |
| Precautions | • Hypersensitivity to any excipient.
• Immune‑suppressed patients (HIV, transplant recipients) – vaccine still safe, but may require a higher total dose or additional boosters; discuss with a clinician.
• Pregnancy / lactation – vaccine is considered safe, but risk–benefit should be evaluated. |
| Warnings | • Allergic reactions (rash, itching, swelling, anaphylaxis) can occur—seek immediate medical care if symptoms appear. |
| Drug interactions | No known pharmacologic interactions, but immunosuppressive drugs (corticosteroids, biologics) may blunt the response. |
---
3. Common Side Effects
| Symptom | Typical frequency | Notes |
|---------|-------------------|-------|
| Injection‑site pain, redness, swelling | 30–60 % | Usually mild; resolves in 1–2 days. |
| Mild fever or chills | 10–15 % | Transient; may be more common after the first dose. |
| Headache | 5–10 % | Usually short‑lived. |
| Nausea | < 5 % | Rare. |
| Severe allergic reactions | < 1 % | Anaphylaxis is rare but possible; treat immediately. |
---
4. Storage & Handling
- Refrigerated (2 – 8 °C) until first use.
- Do not freeze; thaw quickly if frozen.
- Keep out of reach of children—though it’s inactivated, it’s still a vaccine.
---
5. Efficacy & Immunogenicity
- PEP: When given per protocol plus RIG, the vaccine prevents rabies in > 99 % of cases.
- PrEP: A full 3‑dose schedule produces neutralizing antibody titers ≥ 0.5 IU/mL in > 90 % of recipients; a booster may be needed after 4–6 months in some individuals.
---
6. How to Discuss with Your Health Professional
1. Exposure Details: Who was bitten, where (head/face vs. limb), severity, and time since bite.
2. Vaccination History: Have you had rabies vaccine before? If so, when?
3. Allergy History: Any known drug or vaccine allergies?
4. Current Medications: Especially immunosuppressants.
Give the clinician these details so they can choose the correct schedule and whether RIG is needed.
---
7. Frequently Asked Questions
| Question | Answer |
|----------|--------|
| Can I get Imogam if I’m pregnant? | The vaccine is considered safe during pregnancy, but the decision should be made by your healthcare provider based on your exposure risk. |
| What if I miss a dose? | If a dose is missed, resume the schedule as soon as possible; it may shorten the interval between doses. |
| Do I need to get a booster after finishing the series? | For PrEP, a booster 4–6 months after the initial series is sometimes recommended in high‑risk populations, but many clinicians consider the series complete. |
| Can I take antibiotics or NSAIDs with the vaccine? | Yes, but avoid taking NSAIDs (like ibuprofen) right before the first dose, as they may blunt the initial immune response. |
---
Bottom Line
Imogam is a well‑studied, safe rabies vaccine widely used around the world for preventing rabies after exposure and for pre‑exposure protection in high‑risk groups. Follow the recommended dosing schedule, use rabies immune globulin when indicated, and monitor for any allergic reaction. If you have a recent animal bite or are planning to travel to a rabies‑endemic area, discuss vaccination with your healthcare provider ASAP.
Anything else you’d like to know?